Abstract
Background
Few studies have examined the effect of the angiotensin II type I receptor (AT1R) A1166C polymorphism on the antihypertensive effect of the angiotensin-converting-enzyme inhibitor benazepril in patients with hypertension, and no such studies have performed analysis using the Family-Based Association Test (FBAT), The aim of our study was to examine the association between AT1R A1166C gene polymorphism and the antihypertensive effect of benazepril using the FBAT.
Methods and Results
A total of 864 patients (aged, 26–62 years) with essential hypertension were identified in an epidemiological survey and enrolled in this study. Blood pressure (BP) was measured before and after 16 days of treatment with benazepril (10 mg/day). The association between the A1166C gene polymorphism and the antihypertensive effect of benazepril was assessed by FBAT. The frequencies of alleles A and C were 95.1% and 4.9%, respectively. FBAT analysis revealed that the C allele was significantly associated with high baseline diastolic BP (Z = 2.041, p = 0.041), decreased systolic BP after treatment (Z = 2.549, p = 0.011), and decreased diastolic BP after treatment (Z = 2.320, p = 0.020).
Conclusion
Our results, determined using the FBAT, are the first evidence that the AT1R A1166C polymorphism may increase the antihypertensive effect of benazepril in patients with hypertension.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baudin, B., Polymorphism in angiotensin II receptor genes and hypertension. Exp. Physiol., 90, 277–282 (2005).
Bonnardeaux, A., Davies, E., Jeunemaitre, X., Fery, I., Charru, A., Clauser, E., Tiret, L., Cambien, F., Coro, P., and Soubrier, F., Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension, 24, 63–69 (1994).
Ceolotto, G., Papparella, I., Bortoluzzi, A., Strapazzon, G., Ragazzo, F., Bratti, P., Fabricio, A. S., Squarcina, E., Gion, M., Palatini, P., and Semplicini, A., Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am. J. Hypertens., 24, 241–246 (2011).
Hannila-Handelberg, T., Kontula, K. K., Paukku, K., Lehtonen, J. Y., Virtamo, J., Tikkanen, I., and Hiltunen, T. P., Common genetic variations of the renin-angiotensinaldosterone system and response to acute angiotensin Iconverting enzyme inhibition in essential hypertension. J. Hypertens., 28, 771–779 (2010).
Horvath, S., Xu, X., and Laird, N. M., The family based association test method: strategies for studying general genotype—phenotype associations. Eur. J. Hum. Genet., 9, 301–306 (2001).
Kiliszek, M., Burzynska, B., Styczynski, G., Maciag, M., Rabczenko, D., and Opolski, G., A1166C polymorphism of the angiotensin AT1 receptor (AT1R) gene alters endothelial response to statin treatment. Clin. Chem. Lab. Med., 45, 839–842 (2007).
Konoshita, T. and Genomic Disease Outcome Consortium (G-DOC) Study Investigators, Do genetic variants of the Renin-Angiotensin system predict blood pressure response to Renin-Angiotensin system-blocking drugs?: a systematic review of pharmacogenomics in the Renin-Angiotensin system. Curr. Hypertens. Rep., 13, 356–361 (2011).
Laird, N. M. and Lange, C., Family-based designs in the age of large-scale gene-association studies. Nat. Rev. Genet., 7, 385–394 (2006).
Mottl, A. K., Shoham, D. A., and North, K. E., Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review. Genet. Med., 10, 560–574 (2008).
Niu, W. and Qi, Y., Association of the angiotensin II type I receptor gene +1166 A>C polymorphism with hypertension risk: evidence from a meta-analysis of 16474 subjects. Hypertens. Res., 33, 1137–1143 (2010).
Rabinowitz, D. and Laird, N., A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum. Hered., 50, 211–223 (2000).
Su, X., Lee, L., Li, X., Lv, J., Hu, Y., Zhan, S., Cao, W., Mei, L., Tana, Y.-M., Wang, D., Krauss, R. W., Taylor, K. D., Rotter, J. I., and Young, H., Association between angiotensinogen, angiotensin II receptor genes, and blood pressure response to an angiotensin-converting enzyme inhibitor. Circulation, 115, 725–732 (2007).
Wang, J. L., Li, X, Hao, P. P., Feng, X., Chen, Y. G., and Yun, Z., Angiotensin II type 1 receptor gene A1166C polymorphism and essential hypertension in Chinese: a metaanalysis. J. Renin. Angiotensin. Aldosterone. Syst., 11, 127–135 (2010).
Wang, W. Y., Zee, R. Y., and Morris, B. J., Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Clin. Genet., 51, 31–34 (1997).
Yu, H., Lin, S., Jin, L., Yu, Y., Zhong, J., Zhang, Y., and Liu, G., Adenine/cytosine(1166) polymorphism of the angiotensin II type 1 receptor gene and the antihypertensive response to angiotensin-converting enzyme inhibitors. J. Hypertens., 27, 2278–2282 (2009).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, N., Cui, H. & Yang, L. Effect of angiotensin II type I receptor A1166C polymorphism on benazepril action in hypertensive patients: A family-based association test study. Arch. Pharm. Res. 35, 1817–1822 (2012). https://doi.org/10.1007/s12272-012-1015-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-012-1015-9